Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書誌詳細
第一著者:	Mirza, Maisa Tasnim
その他の著者:	Jamiruddin, Dr. Mohd. Raeed
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2023
主題:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
オンライン･アクセス:	http://hdl.handle.net/10361/18147

類似資料

Breast cancer awareness seminars
著者:: Anwer Khan Modern Medical College
出版事項: (2016)

Recent advancement on breast cancer detection and treatment
著者:: Rahman, Sanjida
出版事項: (2023)

Natural products and their combinatory effects in breast cancer treatment
著者:: Siddique, Md. Ayman
出版事項: (2021)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
著者:: Shobnam, Sohana
出版事項: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
著者:: Raihan, Dilraj
出版事項: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
著者:: Akter, Honufa
出版事項: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
著者:: Iqbal, Mohammad Shamim, 等
出版事項: (2017)

The impact of breast cancer on women’s lives in Bangladesh
著者:: Mobashera, Tayeeba Tum
出版事項: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
著者:: Chakraborty, Anuradha
出版事項: (2024)

A review on triple-negative breast cancer and its potential treatment
著者:: Niasa, Jannatul Ferdous
出版事項: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
著者:: Araf, Faiaz Fahim
出版事項: (2024)

Machine learning as an indicator for breast cancer prediction
著者:: Shadman, Tahsin Mohammed, 等
出版事項: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
著者:: Nuha, Nabiha Tahsin
出版事項: (2024)

Breast cancer therapy through Liposomal drug delivery system
著者:: Ome, Nusrat Jahan
出版事項: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
著者:: Lamia
出版事項: (2020)

Early detection of breast cancer using machine learning
著者:: Fuad, Wasi Mohammad
出版事項: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
著者:: Hossain, Mohammad Sorowar, 等
出版事項: (2017)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
著者:: Parvin, Salma, 等
出版事項: (2016)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
著者:: Oishy, Jannatun Noor
出版事項: (2024)

Breast cancer prediction using different machine learning models
著者:: Khandker Al- Muhaimin, 等
出版事項: (2020)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
著者:: Bristy, Israt Zerin
出版事項: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
著者:: Hasan, Sakib
出版事項: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
著者:: Monayem, Kazi Fahim
出版事項: (2024)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
著者:: Haque, Fariha
出版事項: (2023)

Machine learning In breast cancer prognosis and prediction
著者:: Chowdhury, Shah Abul Hasnat, 等
出版事項: (2023)

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
著者:: Ahmad, Sheikh Shafin
出版事項: (2021)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
著者:: Rahman, Sanjida
出版事項: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

Immunotherapy in the treatment of renal cancer
著者:: Shimu, Sumaya
出版事項: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
著者:: Chowdhury, Maisha Mosharrat
出版事項: (2018)

Cancer risk factors: a critical review
著者:: Tabassum, Tahsina
出版事項: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
著者:: Nawar, Anika
出版事項: (2019)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
著者:: Al Mamun, Rafsan, 等
出版事項: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

Targeting BRAFV600E in the treatment of CRC
著者:: Roja, Mashwiyat Samrin
出版事項: (2024)

Role of statins as antagonists of SPARC in gastric cancer
著者:: Shahmat, Rad
出版事項: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
著者:: Pial, Sazia Afrin
出版事項: (2018)